Biotech

All Articles

GSK falls ph. 2 HPV vaccination over absence of best-in-class possible

.GSK has actually junked a stage 2 individual papillomavirus (HPV) vaccine from its own pipe after d...

OS Treatments refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.Operating system Therapies will certainly specify on the NYSE American inventory substitution this ...

ALX's fizzling CD47 feedback cost delivers stock spiraling down

.ALX Oncology's stage 2 gastric cancer cells response rate has actually weakened. After seeing its o...

Ionis centers eye disease from aim ats of Roche-partnered possibility after records dissatisfy

.Another of Ionis Pharmaceuticals' crucial midphase readouts has disappointed desires, prompting the...

Biogen's CEO pointed out no dangerous handle 2023. He's ready to become bold

.While Biogen's pharma peers are hunting for late-stage assets with little bit of threat, chief exec...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Bio has actually been actually a biotech trying to find a pipeline after it ditched its lead...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's ailment system to Denali Rehabs, le...

Takeda faucets brand-new mind of US oncology business-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of substantial management hirings, shooting...

Vertex, hammered through AATD once again, goes down 2 properties on throw away heap

.Vertex's try to handle an unusual genetic disease has attacked one more problem. The biotech tossed...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter earnings file wasn't short of major information. The firm invited a tr...